Alzchem Group AG reports positive business development in the first half of 2023

EQS-Information: Alzchem Group AG

/ Essential phrase(s): Fifty percent Calendar year Report

Alzchem Team AG reports positive small business growth in the to start with 50 % of 2023

03.08.2023 / 07:00 CET/CEST
The issuer is only liable for the material of this announcement.

Alzchem Group AG studies constructive small business improvement in the first fifty percent of 2023

  • Income raise by 3% to EUR 277. million
  • EBITDA grows by 5% to EUR 36.8 million
  • Solid free dollars move of EUR 31.3 million
  • Forecast confirmed: for the complete 12 months, sales predicted to be at the decreased conclusion of the variety, EBITDA at the upper conclude of the range

Trostberg, August 3, 2023 – Alzchem Group AG, a vertically integrated specialty chemical substances provider with a major industry place in chosen specialized niche markets, effectively decoupled itself from the normal craze in the chemical marketplace in the initially 50 percent of 2023. At EUR 277. million, Group income improved by 3% as opposed to the prior-12 months time period, in which EUR 269.8 million was generated.

The Specialty Chemical substances segment all over again proved to be a growth driver, with product sales rising by 12% from EUR 141.5 million to EUR 159. million. This was due in specific to bigger rates than in the earlier yr, but also to quantity development in personal products places, though the phase as a entire recorded a slight decrease in volumes. The Creapure® capacities, which ended up only expanded in the preceding yr, are staying closely utilized as the dietary nutritional supplements products location is encountering higher desire. For this cause, a further expansion is at this time getting applied so that additional capacities will be out there as early as the fourth quarter of 2023.

In the Basics & Intermediates section, income declined by 10% from EUR 115.4 million to EUR 103.4 million, as the cost improves even now realized in some instances were unable to compensate for the volume declines. The sharpest fall in product sales was in the agricultural solution sector with the fertilizer Perlka®. Right here, the higher proportion of energy made use of in creation forces Alzchem to cost product sales selling prices that are substantially larger than all those of community rivals or imported products (from Russia, among the others). In distinction, development was accomplished in the pharmaceutical, agrochemical and primary chemical substances sectors (NITRALZ®). As the pure gasoline-based uncooked resources demanded there (e.g. ammonia) are when again accessible on the current market at a bit reduced rates, it was also achievable to receive far more customers by minimizing offering prices in selected parts.

In line with the constructive Group income advancement, earnings ahead of interest, taxes, depreciation and amortization (EBITDA) also enhanced in the initially fifty percent of 2023. At EUR 36.8 million, the prior year’s determine of EUR 34.9 million was enhanced by 5%, equal to an increased EBITDA margin of 13.3% as opposed with 12.9% in the past 12 months.

Many thanks to unchanged strict functioning funds administration, working money flow enhanced noticeably in the initially 6 months of 2023 by EUR 57. million from EUR -17.2 million to EUR 39.8 million. As a end result, no cost income flow also developed really positively at EUR 31.2 million (initial 50 % of 2022: EUR -32.2 million).

As opposed with 31 December 2022, Team fairness enhanced by EUR 2.4 million to EUR 148.3 million. The Group equity ratio increased from 34.5% to 35.4%.

Andreas Niedermaier, CEO of Alzchem Team AG: “The industry problems continue being massive and the financial natural environment is also extremely fragile. The fact that we yet managed to improve the two revenue and EBITDA in contrast to the earlier 12 months is for that reason a excellent accomplishment. We continue on to attempt to give our shoppers fair price ranges. Even so, long lasting business with destructive contribution margins just to produce larger product sales is not element of this. Rather, we will continue on to target on lucrative products parts in purchase to continue to keep our EBITDA margins steady or even raise them. At the exact same time, we will make further more specific advancement investments.”

In the space of ceramic products and solutions (especially Silzot®), Alzchem is currently analyzing the enlargement of current output capacities. A new application region for higher-purity ceramics is main to drastically higher volume demands in the European source chain right here. In the spot of multi-reason plants, an growth expenditure has previously been initiated, which must lead to growth in quite precise product or service parts.

Alzchem confirms its forecast for the fiscal year 2023. Team gross sales are expected to be instead at the lower conclusion (decrease limit: somewhat escalating, higher restrict: up to EUR 590 million) and EBITDA fairly at the upper end (reduce restrict: slightly increasing, upper restrict: up to EUR 70 million) of the forecast ranges.

The in depth half-12 months money report 2023 is obtainable for down load on the site in the Buyers/Publications part.

About Alzchem

Alzchem is a globally active specialty chemical compounds enterprise that is one particular of the market leaders in most of its fields of exercise. Alzchem positive aspects from the 3 quite distinctive world wide developments local climate alter, populace progress and more time life expectancy in a unique way. Alzchem goods can present beautiful solutions for attaining the resulting social aims in a multitude of various programs.

The corporation sees fascinating development potential clients for itself in the parts of human and animal nutrition and agriculture in particular. As a consequence of populace progress, it is important to accomplish effective foods creation. Pharmaceutical raw resources and creatine items can contribute to a wholesome previous age as existence expectancy boosts. Alzchem is experiencing up to the intention of sustainability arising from local climate alter in the industry of renewable energies and across the total company. The fields of fine chemical substances and metallurgy present just as excellent a viewpoint. 

Alzchem Team AG’s broad solution range consists of dietary dietary supplements, precursors for PCR exams and pharmaceutical raw resources. These choices are the company’s response to global developments and developments. Alzchem is ideally positioned in this respect and considers by itself effectively prepared for an environmental foreseeable future and global developments.

The business employs all over 1,680 people today at four output web sites in Germany and a plant in Sweden, as perfectly as three gross sales organizations in the Usa, China and England. Alzchem produced Team sales of all-around EUR 542.2 million and EBITDA of all over EUR 61.4 million in 2022.

03.08.2023 CET/CEST Dissemination of a Company News, transmitted by EQS News – a service of EQS Team AG.
The issuer is only liable for the information of this announcement.

The EQS Distribution Providers include things like Regulatory Announcements, Financial/Company Information and Press Releases.
Archive at

Related posts